These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7097982)

  • 21. International collaborative study on standardization of bacterial sensitivity to fosfomycin.
    Andrews JM; Baquero F; Beltran JM; Canton E; Crokaert F; Gobernado M; Gomez-Ius R; Loza E; Navarro M; Olay T
    J Antimicrob Chemother; 1983 Oct; 12(4):357-61. PubMed ID: 6643331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the disc method for the determination of bacterial sensitivity to sulfobenzylpenicillin (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1975 Dec; 28(6):745-52. PubMed ID: 1104912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibility testing with fosfomycin in an agar diffusion test on Mueller-Hinton agar].
    Grimm H; Haag R
    Immun Infekt; 1982 Jul; 10(4):159-63. PubMed ID: 6813250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
    Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conditions influencing the activity of fosfomycin in vitro (author's transl)].
    Haag R; Vömel W
    Immun Infekt; 1979 Dec; 7(6):202-9. PubMed ID: 396228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.
    Barry AL; Pfaller MA; Fuchs PC; Tenover FC; Reller LB; Allen SD; Hardy DJ; Gerlach EH
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):352-6. PubMed ID: 8354302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae.
    Pasteran F; Lucero C; Rapoport M; Guerriero L; Barreiro I; Albornoz E; Veliz O; Corso A
    J Infect Dev Ctries; 2012 May; 6(5):452-6. PubMed ID: 22610713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
    Inouye S; Watanabe T; Tsuruoka T; Kitasato I
    J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is a New Standard Needed for Diffusion Methods for In Vitro Susceptibility Testing of Fosfomycin against Pseudomonas aeruginosa?
    Díez-Aguilar M; Martínez-García L; Cantón R; Morosini MI
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1158-61. PubMed ID: 26643341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest.
    Horii T; Kimura T; Odagiri T; Shibayama K; Ohta M
    J Infect Chemother; 2000 Mar; 6(1):30-4. PubMed ID: 11810528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.
    Alés JM
    Chemotherapy; 1977; 23 Suppl 1():94-8. PubMed ID: 401722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fosfomycin: interpretation of inhibition zones obtained with the Bauer-Kirby agar disk diffusion susceptibility test.
    Traub WH; Spohr M
    Chemotherapy; 1983; 29(3):208-12. PubMed ID: 6872618
    [No Abstract]   [Full Text] [Related]  

  • 36. [The correlation between the MICs deduced from Showa disk method and the MICs determined by micro-dilution method].
    Moroizumi S; Kasitani F; Isikawa M; Iwata M; Ohno A; Yamaguchi K
    Rinsho Byori; 1994 Oct; 42(10):1062-8. PubMed ID: 7996716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1984 May; 37(5):791-801. PubMed ID: 6090721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
    Renzini G; Oliva B
    G Ital Chemioter; 1977; 23(2):117-22. PubMed ID: 606610
    [No Abstract]   [Full Text] [Related]  

  • 40. Sensitivity of Vibrio spp. to fosfomycin.
    Reparaz J; Fernández C
    Chemotherapy; 1977; 23 Suppl 1():58-62. PubMed ID: 832545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.